mRNA Melanoma Breakthrough
2:11–2:41 · 30s
A researcher shares five-year data showing nearly 69% of high-risk melanoma patients remain cancer-free after a personalized mRNA vaccine plus immunotherapy.
2:11–2:41 · 30s
A researcher shares five-year data showing nearly 69% of high-risk melanoma patients remain cancer-free after a personalized mRNA vaccine plus immunotherapy.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.